Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 20

1.

Evaluation of rapid and sensitive DNA extraction methods for detection of cytomegalovirus in dried blood spots.

Koontz D, Dollard S, Cordovado S.

J Virol Methods. 2019 Mar;265:117-120. doi: 10.1016/j.jviromet.2019.01.005. Epub 2019 Jan 11.

PMID:
30639422
2.

Newborn Screening Quality Assurance Program for CFTR Mutation Detection and Gene Sequencing to Identify Cystic Fibrosis.

Hendrix MM, Foster SL, Cordovado SK.

J Inborn Errors Metab Screen. 2016 Jan-Dec;4. doi: 10.1177/2326409816661358. Epub 2016 Aug 1.

4.

Improving newborn screening for cystic fibrosis using next-generation sequencing technology: a technical feasibility study.

Baker MW, Atkins AE, Cordovado SK, Hendrix M, Earley MC, Farrell PM.

Genet Med. 2016 Mar;18(3):231-8. doi: 10.1038/gim.2014.209. Epub 2015 Feb 12.

5.

Novel method to characterize CYP21A2 in Florida patients with congenital adrenal hyperplasia and commercially available cell lines.

Greene CN, Cordovado SK, Turner DP, Keong LM, Shulman D, Mueller PW.

Mol Genet Metab Rep. 2014 Aug 8;1:312-323. eCollection 2014.

6.

Developmental genetics of secretory vesicle acidification during Caenorhabditis elegans spermatogenesis.

Gleason EJ, Hartley PD, Henderson M, Hill-Harfe KL, Price PW, Weimer RM, Kroft TL, Zhu GD, Cordovado S, L'Hernault SW.

Genetics. 2012 Jun;191(2):477-91. doi: 10.1534/genetics.112.139618. Epub 2012 Mar 23.

7.

CFTR mutation analysis and haplotype associations in CF patients.

Cordovado SK, Hendrix M, Greene CN, Mochal S, Earley MC, Farrell PM, Kharrazi M, Hannon WH, Mueller PW.

Mol Genet Metab. 2012 Feb;105(2):249-54. doi: 10.1016/j.ymgme.2011.10.013. Epub 2011 Oct 26.

8.

Implementation of the first worldwide quality assurance program for cystic fibrosis multiple mutation detection in population-based screening.

Earley MC, Laxova A, Farrell PM, Driscoll-Dunn R, Cordovado S, Mogayzel PJ Jr, Konstan MW, Hannon WH.

Clin Chim Acta. 2011 Jul 15;412(15-16):1376-81. doi: 10.1016/j.cca.2011.04.011. Epub 2011 Apr 14.

9.

Proficiency testing of human leukocyte antigen-DR and human leukocyte antigen-DQ genetic risk assessment for type 1 diabetes using dried blood spots.

Dantonio P, Meredith-Molloy N, Hagopian WA, She JX, Akolkar B, Cordovado SK, Hendrix M, Henderson LO, Hannon WH, Vogt RF.

J Diabetes Sci Technol. 2010 Jul 1;4(4):929-41.

10.

Novel human leukocyte antigen class I and class II alleles identified by sequence-based typing in the Genetics of Kidneys in Diabetes (GoKinD) study population.

Cordovado SK, Hancock LN, Hendrix M, Greene CN, Mueller PW.

Hum Immunol. 2009 Sep;70(9):747-9. doi: 10.1016/j.humimm.2009.06.011. Epub 2009 Jun 16.

PMID:
19539002
11.

Assessment of DNA contamination from dried blood spots and determination of DNA yield and function using archival newborn dried blood spots.

Cordovado SK, Earley MC, Hendrix M, Driscoll-Dunn R, Glass M, Mueller PW, Hannon WH.

Clin Chim Acta. 2009 Apr;402(1-2):107-13. doi: 10.1016/j.cca.2008.12.028. Epub 2008 Dec 31.

PMID:
19161996
12.

Sequence variants in the PLEKHH2 region are associated with diabetic nephropathy in the GoKinD study population.

Greene CN, Keong LM, Cordovado SK, Mueller PW.

Hum Genet. 2008 Oct;124(3):255-62. doi: 10.1007/s00439-008-0548-y. Epub 2008 Aug 28.

PMID:
18752002
13.

Nephropathy in type 1 diabetes is diminished in carriers of HLA-DRB1*04: the genetics of kidneys in diabetes (GoKinD) study.

Cordovado SK, Zhao Y, Warram JH, Gong H, Anderson KL, Hendrix MM, Hancock LN, Cleary PA, Mueller PW.

Diabetes. 2008 Feb;57(2):518-22. Epub 2007 Nov 26.

14.

A screening system for detecting genetic risk markers of type 1 diabetes in dried blood spots.

Dantonio P, Meredith N, Earley M, Cordovado S, Callan WJ, Rollin D, Morris D, Vogt RF, Hannon WH.

Diabetes Technol Ther. 2006 Aug;8(4):433-43.

PMID:
16939368
15.

Genetics of Kidneys in Diabetes (GoKinD) study: a genetics collection available for identifying genetic susceptibility factors for diabetic nephropathy in type 1 diabetes.

Mueller PW, Rogus JJ, Cleary PA, Zhao Y, Smiles AM, Steffes MW, Bucksa J, Gibson TB, Cordovado SK, Krolewski AS, Nierras CR, Warram JH.

J Am Soc Nephrol. 2006 Jul;17(7):1782-90. Epub 2006 Jun 14.

16.

Identification of two novel DQA1 alleles, DQA1*0107 and DQA1*0602, by sequence-based typing in the GoKinD population.

Hancock LN, Cordovado SK, Hendrix M, Simone AE, Mueller PW.

Hum Immunol. 2005 Dec;66(12):1248-53. Epub 2006 Mar 15.

PMID:
16690412
17.

High-resolution genotyping of HLA-DQA1 in the GoKinD study and identification of novel alleles HLA-DQA1*040102, HLA-DQA1*0402 and HLA-DQA1*0404.

Cordovado SK, Hancock LN, Simone AE, Hendrix M, Mueller PW.

Tissue Antigens. 2005 May;65(5):448-58.

PMID:
15853899
19.
20.

Current activities at the Centers for Disease Control and Prevention's National Diabetes Laboratory.

Sampson EJ, Barr JR, Cordovado SK, Hannon WH, Henderson LO, Johnson AB, Miller D, Mueller PW, Myers GL, Pirkle JL, Schleicher RL, Steinberg K, Sussman D, Vogt RF.

Diabetes Technol Ther. 1999 Winter;1(4):403-9.

PMID:
11474824

Supplemental Content

Loading ...
Support Center